These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 29691802

  • 21. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides.
    Di Pasquale E, Fantini J, Chahinian H, Maresca M, Taïeb N, Yahi N.
    J Mol Biol; 2010 Mar 19; 397(1):202-18. PubMed ID: 20114052
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death.
    Mahul-Mellier AL, Vercruysse F, Maco B, Ait-Bouziad N, De Roo M, Muller D, Lashuel HA.
    Cell Death Differ; 2015 Dec 19; 22(12):2107-22. PubMed ID: 26138444
    [Abstract] [Full Text] [Related]

  • 24. Phosphatidylcholine and Phosphatidylserine Uniquely Modify the Secondary Structure of α-Synuclein Oligomers Formed in Their Presence at the Early Stages of Protein Aggregation.
    Dou T, Kurouski D.
    ACS Chem Neurosci; 2022 Aug 17; 13(16):2380-2385. PubMed ID: 35904551
    [Abstract] [Full Text] [Related]

  • 25. C-terminal truncation is a prominent post-translational modification of human erythrocyte α-synuclein.
    Amagai R, Otomo R, Yoshioka S, Nagano H, Hashimoto N, Sakakibara R, Tanaka T, Okado-Matsumoto A.
    J Biochem; 2024 May 31; 175(6):649-658. PubMed ID: 38308089
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
    Bergeron M, Motter R, Tanaka P, Fauss D, Babcock M, Chiou SS, Nelson S, San Pablo F, Anderson JP.
    Neuroscience; 2014 Jan 03; 256():72-82. PubMed ID: 24128992
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The chaperone activity of α-synuclein: Utilizing deletion mutants to map its interaction with target proteins.
    Rekas A, Ahn KJ, Kim J, Carver JA.
    Proteins; 2012 May 03; 80(5):1316-25. PubMed ID: 22274962
    [Abstract] [Full Text] [Related]

  • 30. Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae.
    Soper JH, Roy S, Stieber A, Lee E, Wilson RB, Trojanowski JQ, Burd CG, Lee VM.
    Mol Biol Cell; 2008 Mar 03; 19(3):1093-103. PubMed ID: 18172022
    [Abstract] [Full Text] [Related]

  • 31. Lysine residues at the first and second KTKEGV repeats mediate α-Synuclein binding to membrane phospholipids.
    Zarbiv Y, Simhi-Haham D, Israeli E, Elhadi SA, Grigoletto J, Sharon R.
    Neurobiol Dis; 2014 Oct 03; 70():90-8. PubMed ID: 24905915
    [Abstract] [Full Text] [Related]

  • 32. Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein.
    Tsigelny IF, Bar-On P, Sharikov Y, Crews L, Hashimoto M, Miller MA, Keller SH, Platoshyn O, Yuan JX, Masliah E.
    FEBS J; 2007 Apr 03; 274(7):1862-77. PubMed ID: 17381514
    [Abstract] [Full Text] [Related]

  • 33. Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease.
    Wang X, Yu S, Li F, Feng T.
    Neurosci Lett; 2015 Jul 10; 599():115-9. PubMed ID: 25998655
    [Abstract] [Full Text] [Related]

  • 34. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.
    Harischandra DS, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG.
    Toxicol Sci; 2015 Feb 10; 143(2):454-68. PubMed ID: 25416158
    [Abstract] [Full Text] [Related]

  • 35. The nuclear accumulation of alpha-synuclein is mediated by importin alpha and promotes neurotoxicity by accelerating the cell cycle.
    Ma KL, Song LK, Yuan YH, Zhang Y, Han N, Gao K, Chen NH.
    Neuropharmacology; 2014 Jul 10; 82():132-42. PubMed ID: 23973294
    [Abstract] [Full Text] [Related]

  • 36. Interference of alpha-synuclein with cAMP/PKA-dependent CREB signaling for tyrosine hydroxylase gene expression in SK-N-BE(2)C cells.
    Kim SS, Moon KR, Choi HJ.
    Arch Pharm Res; 2011 May 10; 34(5):837-45. PubMed ID: 21656370
    [Abstract] [Full Text] [Related]

  • 37. The Molecular Mechanism of Alpha-Synuclein Dependent Regulation of Protein Phosphatase 2A Activity.
    Qu J, Yan H, Zheng Y, Xue F, Zheng Y, Fang H, Chang Y, Yang H, Zhang J.
    Cell Physiol Biochem; 2018 May 10; 47(6):2613-2625. PubMed ID: 29996119
    [Abstract] [Full Text] [Related]

  • 38. Alpha-synuclein functions as a negative regulator for expression of tyrosine hydroxylase.
    Li YH, Gao N, Ye YW, Li X, Yu S, Yang H, Uéda K, Chan P.
    Acta Neurol Belg; 2011 Jun 10; 111(2):130-5. PubMed ID: 21748932
    [Abstract] [Full Text] [Related]

  • 39. Membrane differentiation in human erythroid cells: unique profiles of cell surface glycoproteins expressed in erythroblasts in vitro from three ontogenic stages.
    Fukuda M, Fukuda MN, Papayannopoulou T, Hakomori S.
    Proc Natl Acad Sci U S A; 1980 Jun 10; 77(6):3474-8. PubMed ID: 6774338
    [Abstract] [Full Text] [Related]

  • 40. Erythroblast enucleation is a dynein-dependent process.
    Kobayashi I, Ubukawa K, Sugawara K, Asanuma K, Guo YM, Yamashita J, Takahashi N, Sawada K, Nunomura W.
    Exp Hematol; 2016 Apr 10; 44(4):247-56.e12. PubMed ID: 26724640
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.